CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

In an extremely rare case, an unnamed 69-year-old man who had cirrhosis and liver cancer underwent a liver transplant and ...

The results were promising. Men on the omega-3-rich diet experienced a 15% decrease in the Ki-67 index, while the control ...

Movember aims to raise awareness of men’s health for the month of November. Prostate cancer is the most common (non-cutaneous ...

A deli owner has hailed a miracle new drug trial after seeing his aggressive bladder cancer finally ... the most common type ...

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Roughly 70 percent of patients are diagnosed with prostate cancers in the early stages of the disease, before surgery, ...